APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Extracorporeal Membrane Oxygenation (ECMO) Systems

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

Selected research

Market Structure

Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173906070321 December 2025184 pages

Choose your research edition.

Industry ResearchExtracorporeal Membrane Oxygenation (ECMO) Systems Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Extracorporeal Membrane Oxygenation (ECMO) Systems Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Extracorporeal Membrane Oxygenation (ECMO) Systems Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

The global extracorporeal membrane oxygenation (ECMO) system market is dominated by North America (41%) and Europe (34%). The market is growing due to improved patient safety and awareness among the doctors and patients. The Asian market is growing due to increasing adoption rate of ECMO machine in hospitals, success rate of ECMO & government initiatives, and growing awareness towards ECMO.

This market is segmented and forecast on the basis of modality, application and geography. The modality comprises of Veno Artrial (VA), Veno Venous (VV), the Veno Venous (VV) contributed to 61.82% of global market of ECMO system industry.

Read the full market overview

For China market, the industry is developing rapidly. The main players are Medtronic, Maquet, Sorin, Terumo and Xenios. Medtronic and Maquet enjoy more than 50% market share.

This report provides an overview of the global Extracorporeal Membrane Oxygenation (ECMO) Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Extracorporeal Membrane Oxygenation (ECMO) Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Extracorporeal Membrane Oxygenation (ECMO) Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Extracorporeal Membrane Oxygenation (ECMO) Systems market size, projected growth trends, production technologies, key applications, and end-use industries.

Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Company

Medtronic

Maquet

Sorin

Terumo

Xenios

Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Type

VA (Veno-Arterial) ECMO

VV (Veno-Venous) ECMO

Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Application

Neonatal

Pediatric

Adult

Extracorporeal Membrane Oxygenation (ECMO) Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Extracorporeal Membrane Oxygenation (ECMO) Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Extracorporeal Membrane Oxygenation (ECMO) Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Extracorporeal Membrane Oxygenation (ECMO) Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Extracorporeal Membrane Oxygenation (ECMO) Systems market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Extracorporeal Membrane Oxygenation (ECMO) Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Extracorporeal Membrane Oxygenation (ECMO) Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Extracorporeal Membrane Oxygenation (ECMO) Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Trends Table 2. Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Drivers Table 3. Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Opportunities and Challenges Table 4. Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Restraints Table 5. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Manufacturers Table 9. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Average Sales Price (K USD/Unit) of Manufacturers (2021-2026) Table 10. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Manufacturers, Product Type & Application Table 13. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Extracorporeal Membrane Oxygenation (ECMO) Systems by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of VA (Veno-Arterial) ECMO Table 17. Major Manufacturers of VV (Veno-Venous) ECMO Table 18. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type 2021 VS 2025 VS 2032 (Units) Table 19. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type (2021-2026) & (Units) Table 20. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type (2027-2032) & (Units) Table 21. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Type (2021-2026) Table 22. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Type (2027-2032) Table 23. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 24. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type (2021-2026) & (Units) Table 25. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type (2027-2032) & (Units) Table 26. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Type (2021-2026) Table 27. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Neonatal Table 29. Major Manufacturers of Pediatric Table 30. Major Manufacturers of Adult Table 31. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application (2021-2026) & (Units) Table 33. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application (2027-2032) & (Units) Table 34. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Application (2021-2026) Table 35. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Application (2027-2032) Table 36. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 37. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application (2021-2026) & (Units) Table 38. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application (2027-2032) & (Units) Table 39. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Application (2021-2026) Table 40. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Application (2027-2032) Table 41. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (2021-2026) & (Units) Table 43. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Region (2021-2026) Table 44. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Forecasted by Region (2027-2032) & (Units) Table 45. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 47. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2026) & (Units) Table 48. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2027-2032) & (Units) Table 49. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2026) & (Units) Table 51. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2027-2032) & (Units) Table 52. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2026) & (Units) Table 54. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2027-2032) & (Units) Table 55. South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2026) & (Units) Table 57. South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2027-2032) & (Units) Table 58. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Region (2021-2026) Table 62. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Region (2027-2032) Table 63. Medtronic Company Information Table 64. Medtronic Business Overview Table 65. Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio Table 67. Medtronic Recent Development Table 68. Maquet Company Information Table 69. Maquet Business Overview Table 70. Maquet Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Maquet Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio Table 72. Maquet Recent Development Table 73. Sorin Company Information Table 74. Sorin Business Overview Table 75. Sorin Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sorin Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio Table 77. Sorin Recent Development Table 78. Terumo Company Information Table 79. Terumo Business Overview Table 80. Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio Table 82. Terumo Recent Development Table 83. Xenios Company Information Table 84. Xenios Business Overview Table 85. Xenios Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Units), Price (K USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Xenios Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio Table 87. Xenios Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Extracorporeal Membrane Oxygenation (ECMO) Systems Distributors List Table 91. Extracorporeal Membrane Oxygenation (ECMO) Systems Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Extracorporeal Membrane Oxygenation (ECMO) Systems Product Image Figure 2. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size (2021-2032) & (US$ Million) Figure 4. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (2021-2032) & (Units) Figure 5. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Average Price (K USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Extracorporeal Membrane Oxygenation (ECMO) Systems Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. VA (Veno-Arterial) ECMO Image Figure 9. VV (Veno-Venous) ECMO Image Figure 10. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 11. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Type (2021-2032) Figure 13. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Type (2021-2032) Figure 16. Neonatal Image Figure 17. Pediatric Image Figure 18. Adult Image Figure 19. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Application (2021-2032) Figure 22. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Application (2021-2032) Figure 25. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 26. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Country (2021-2032) Figure 27. U.S. Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 28. Canada Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 29. Mexico Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 30. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Country (2021-2032) Figure 32. Germany Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 33. France Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 34. U.K. Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 35. Italy Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 36. Netherlands Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 37. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Country (2021-2032) Figure 39. China Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 40. Japan Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 41. South Korea Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 42. Southeast Asia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 43. India Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 44. Australia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 45. South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Country (2021-2032) Figure 47. Brazil Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 48. South Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 49. Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 50. Turkey Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 51. Argentina Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 52. UAE Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 53. Egypt Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 54. Chile Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2021-2032) & (Units) Figure 55. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032) & (US$ Million) Figure 58. North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032) & (US$ Million) Figure 60. Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Extracorporeal Membrane Oxygenation (ECMO) Systems Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Extracorporeal Membrane Oxygenation (ECMO) Systems Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • VA (Veno-Arterial) ECMO
  • VV (Veno-Venous) ECMO
Applications
  • Neonatal
  • Pediatric
  • Adult
Companies covered
  • Medtronic
  • Maquet
  • Sorin
  • Terumo
  • Xenios

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market Dynamics
  1. 2.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Trends
  2. 2.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Drivers
  3. 2.3 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Opportunities and Challenges
  4. 2.4 Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Restraints
3 Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Manufacturers
  1. 3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Manufacturers (2021-2026)
  3. 3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Manufacturers, Product Type & Application
  7. 3.7 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Extracorporeal Membrane Oxygenation (ECMO) Systems Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Extracorporeal Membrane Oxygenation (ECMO) Systems Tier 1, Tier 2, and Tier 3
4 Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Type
  1. 4.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Type Introduction
  2. 4.1.1 VA (Veno-Arterial) ECMO
  3. 4.1.2 VV (Veno-Venous) ECMO
  4. 4.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type
  5. 4.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Type (2021-2032)
  7. 4.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Type (2021-2032)
  8. 4.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type
  9. 4.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Type (2021-2032)
  11. 4.3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Type (2021-2032)
5 Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Application
  1. 5.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Application Introduction
  2. 5.1.1 Neonatal
  3. 5.1.2 Pediatric
  4. 5.1.3 Adult
  5. 5.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application
  6. 5.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Application (2021-2032)
  8. 5.2.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Share by Application (2021-2032)
  9. 5.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application
  10. 5.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Application (2021-2032)
  12. 5.3.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Application (2021-2032)
6 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region
  1. 6.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (2021-2032)
  3. 6.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Region (2021-2026)
  4. 6.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region
  1. 7.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region
  2. 7.1.1 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (2021-2026)
  4. 7.1.3 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Region (2027-2032)
  5. 7.1.4 Global Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032)
  8. 7.2.2 North America Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032)
  11. 7.3.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Maquet
  8. 8.2.1 Maquet Company Information
  9. 8.2.2 Maquet Business Overview
  10. 8.2.3 Maquet Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Maquet Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
  12. 8.2.5 Maquet Recent Developments
  13. 8.3 Sorin
  14. 8.3.1 Sorin Company Information
  15. 8.3.2 Sorin Business Overview
  16. 8.3.3 Sorin Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sorin Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
  18. 8.3.5 Sorin Recent Developments
  19. 8.4 Terumo
  20. 8.4.1 Terumo Company Information
  21. 8.4.2 Terumo Business Overview
  22. 8.4.3 Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
  24. 8.4.5 Terumo Recent Developments
  25. 8.5 Xenios
  26. 8.5.1 Xenios Company Information
  27. 8.5.2 Xenios Business Overview
  28. 8.5.3 Xenios Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Xenios Extracorporeal Membrane Oxygenation (ECMO) Systems Product Portfolio
  30. 8.5.5 Xenios Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Value Chain Analysis
  2. 9.1.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Extracorporeal Membrane Oxygenation (ECMO) Systems Production Mode & Process
  6. 9.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Distributors
  9. 9.2.3 Extracorporeal Membrane Oxygenation (ECMO) Systems Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst